Advertisement
Home Tags Clots

Tag: Clots

For patients undergoing liver surgery

Extended Thromboprophylaxis Safe, Effective After Liver Surgery

0
Severe complication rate 5.6 percent, with no 90-day mortalities
Height is an independent predictor of venous thromboembolism

Greater Height Tied to Higher Risk of Venous Thromboembolism

0
Study using sibling pairs discordant for height reduces chance of familial confounding
For elderly patients treated with vitamin K antagonists for venous thromboembolism

CYP2C9 Variants Linked to Clinical Events in VTE

0
Risk of any clinical event, death, non-major bleeding up for seniors treated with vitamin K antagonists
About one in 20 patients with unprovoked venous thromboembolism have occult cancer detected within one year

Occult Cancer Found in ~5 Percent With Unprovoked VTE

0
Prevalence of cancer increases linearly with age; is seven-fold higher in patients aged 50 years or older
Online training for nurses has been found to increase hospital patients' use of venous thromboembolism prophylaxis

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

0
Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism
The risk of arterial thromboembolism is increased in the short term among patients with incident cancer

Short-Term Risk of Arterial Embolism Up in Cancer Patients

0
Increased risk of arterial thromboembolism, MI, ischemic stroke for cancer patients
Exposure to fire is associated with activation of platelets

Firefighters Exhibit Increased Cardiovascular Impairment

0
Increased thrombus formation, increased platelet-monocyte binding with exposure to fire simulation
Patients with isolated superficial vein thrombosis have a similar overall risk of recurrence as those with proximal deep vein thrombosis

Overall Risk of VTE Recurrence Similar for iSVT, Proximal DVT

0
Isolated superficial vein thrombosis tied to increased risk of iSVT recurrence, lower risk of deep-VTE events
Among patients with intermediate- to high-risk pulmonary embolism

Long-Term Thrombolytic Tx No Benefit in Intermediate-Risk PE

0
Findings at three years for tenecteplase vs placebo in patients with intermediate-risk pulmonary embolism
Rivaroxaban is associated with reduced risk of recurrent events among patients with venous thromboembolism in equipoise for continued anticoagulation

ACC: Rivaroxaban Beats Aspirin for Lower Risk of Recurrent VTE

0
Low dose cuts risk in equipoise for continued anticoagulation; rate of bleeding similar to aspirin